Palatin Technologies Inc stock is traded at $5.79, with a volume of 4,496. It is up +1.40% in the last 24 hours and down -38.47% over the past month. Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Previous Close:
$5.71
Open:
$5.93
24h Volume:
4,496
Relative Volume:
0.11
Market Cap:
$10.31M
Revenue:
$12.88M
Net Income/Loss:
-$6.25M
P/E Ratio:
-
EPS:
-$1.37
Net Cash Flow:
-$14.98M
1W Performance:
+15.80%
1M Performance:
-38.47%
6M Performance:
-69.53%
1Y Performance:
0.00%
1-Day Range:
$5.67$5.93
1-Week Range:
$4.76$6.20
52-Week Range:
$4.51$31.00
Palatin Technologies Inc Stock (PTN) Company Profile
Name
Palatin Technologies IncSector
HealthcareIndustry
BiotechnologyPhone
609-495-2200Address
4B CEDAR BROOK DRIVE, CRANBURY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS